Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study
Dalby, M.; Montalescot, G.; Bal dit Sollier, C.; Vicaut, E.; Soulat, T.; Collet, J.Philippe.; Choussat, Rémi.; Gallois, V.; Drobinski, Gérard.; Drouet, L.; Thomas, D.
Journal of the American College of Cardiology 43(2): 162-168
2004
ISSN/ISBN: 0735-1097
PMID: 14736431
DOI: 10.1016/j.accreview.2004.03.050
Accession: 012047070
OBJECTIVES The present study hypothesis was that eptifibatide offered further antiplatelet efficacy above clopidogrel in non-ST-elevation myocardial infarction (NSTEMI) patients before an expeditive coronary intervention.
PDF emailed within 0-6 h: $19.90
Related References
Dalby, M.C.; Montalescot, G.; Bal Dit Sollier, C.; Vicaut, E.; Collet, J.P.; Choussat, R.; Gallois, V.; Drobinski, G.; Drouet, L.; Thomas, D. 2003: Eptifibatide provides additional platelet inhibition in non-ST elevation myocardial infarction patients already treated with aspirin and clopidogrel Results of the PEACE Study Journal of the American College of Cardiology 41(6 Suppl A): 365AGurbel, P.A.; Bliden, K.P.; Saucedo, J.F.; Suarez, T.A.; DiChiara, J.; Antonino, M.J.; Mahla, E.; Singla, A.; Herzog, W.R.; Bassi, A.K.; Hennebry, T.A.; Gesheff, T.B.; Tantry, U.S. 2009: Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study Journal of the American College of Cardiology 53(8): 648-657
Milicic, D.; Lovric, D.; Skoric, B.; Narancic-Skoric, K.; Gornik, I.; Sertic, J. 2011: Platelet response to standard aspirin and clopidogrel treatment correlates with long-term outcome in patients with acute ST-elevation myocardial infarction International Journal of Cardiology 153(2): 227-229
Jeong, Y-Hoon.; Tantry, U.S.; Kim, I-Suk.; Koh, J-Sin.; Kwon, T.Jung.; Park, Y.; Hwang, S-Jae.; Bliden, K.P.; Kwak, C.Hwan.; Hwang, J-Yong.; Gurbel, P.A. 2011: Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin Circulation. Cardiovascular Interventions 4(6): 585-594
Gibson, C.Michael.; Jennings, L.K.; Murphy, S.A.; Lorenz, D.P.; Giugliano, R.P.; Harrington, R.A.; Cholera, S.; Krishnan, R.; Califf, R.M.; Braunwald, E. 2004: Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy Circulation 110(6): 679-684
Morrow, D.A.; Wiviott, S.D.; White, H.D.; Nicolau, J.C.; Bramucci, E.; Murphy, S.A.; Bonaca, M.P.; Ruff, C.T.; Scirica, B.M.; McCabe, C.H.; Antman, E.M.; Braunwald, E. 2009: Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction Circulation 119(21): 2758-2764
Udell, J.A.; Braunwald, E.; Antman, E.M.; Antman, E.M.; Murphy, S.A.; Montalescot, G.; Wiviott, S.D. 2014: Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38) Jacc. Cardiovascular Interventions 7(6): 604-612
Jeong, Y.-H.; Cho, J.-H.; Kang, M.-K.; Koh, J.-S.; Kim, I.-S.; Park, Y.; Hwang, S.-J.; Kwak, C.H.; Hwang, J.-Y. 2010: Smoking at least 10 cigarettes per day increases platelet inhibition by clopidogrel in patients with ST-segment-elevation myocardial infarction Thrombosis Research 126(4): E334-E338
2012: Efient® (prasugrel) vs Plavix® (clopidogrel) chez des patients présentant un syndrome coronaire aigu AI/NSTEMI traité médicalement sans revascularisation - The TRILOGYACS Trial. Efient® (prasugrel) vs Plavix® (clopidogrel). A phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI) who were managed medically without an artery-opening procedure Congres de l'Esc 34(SEP): 261-264
Gersh, B.J. 2006: Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction With ST-Segment Elevation Yearbook of Cardiology 2006: 222-224
Jabaren, M.; Desai, D.M.; Arabi, A.; Kareti, G.; Chen-Scarabelli, C.; Rosman, H.S. 2006: Effect of clopidogrel plus aspirin on ST segments in patients with ST-elevation acute myocardial infarction American Journal of Cardiology 98(11): 1435-1438
Sabatine, M.S.; Cannon, C.P.; Gibson, C.Michael.; López-Sendón, J.L.; Montalescot, G.; Theroux, P.; Claeys, M.J.; Cools, F.; Hill, K.A.; Skene, A.M.; McCabe, C.H.; Braunwald, E. 2005: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation New England Journal of Medicine 352(12): 1179-1189
Abetel, G.; Vuille, C. 2012: ST segment elevation-acute myocardial infarction management at the office: clopidogrel or aspirin? Revue Medicale Suisse 8(338): 912-913
Kohli, P.; Udell, J.A.; Murphy, S.A.; Cannon, C.P.; Antman, E.M.; Braunwald, E.; Wiviott, S.D. 2014: Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMi 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38) Journal of the American College of Cardiology 63(3): 225-232
Alexopoulos, D.; Theodoropoulos, K.C.; Stavrou, E.F.; Xanthopoulou, I.; Kassimis, G.; Tsigkas, G.; Damelou, A.; Davlouros, P.; Hahalis, G.; Athanassiadou, A. 2012: Prasugrel versus high dose clopidogrel to overcome early high on clopidogrel platelet reactivity in patients with ST elevation myocardial infarction Cardiovascular Drugs and Therapy 26(5): 393-400
Sun, J.; Yang, G.-H.; Liu, J.-X.; Liu, X.-L.; Ma, Y.-Q.; Lu, R.-Y.; Zhang, Y.-Y.; Chen, S.-B.; Zhao, J.-H.; Ji, W.-J.; Zhou, X.; Li, Y.-M. 2018: Discordance Between VASP Phosphorylation and Platelet Aggregation in Defining High On-Clopidogrel Platelet Reactivity After ST-Segment Elevation Myocardial Infarction Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 24(1): 47-54
Fuchs, I.; Spiel, A.O.; Frossard, M.; Derhaschnig, U.; Riedmüller, E.; Jilma, B. 2010: Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy Critical Care Medicine 38(6): 1423-1429
Gibson, C.M.; Murphy, S.A.; Pride, Y.B.; Kirtane, A.J.; Aroesty, J.M.; Stein, E.B.; Ciaglo, L.N.; Southard, M.C.; Sabatine, M.S.; Cannon, C.P.; Braunwald, E. 2008: Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study American Heart Journal 155(1): 133-139
Gibson, C.M.; Murphy, S.A.; Braunwald, E.; Pride, Y.B.; Kirtane, A.J.; Aroesty, J.M.; Stein, E.B.; Ciaglo, L.N.; Southard, M.C.; Sabatine, M.S.; Cannon, C.P.; Timi, S.G. 2008: Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction : A Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study The American Heart Journal 155(1): 133-139
Sibbing, D.; Bernlochner, I.; Schulz, S.; Massberg, S.; Schömig, A.; Mehilli, J.; Kastrati, A. 2012: The impact of smoking on the antiplatelet action of clopidogrel in non-ST-elevation myocardial infarction patients: results from the ISAR-REACT 4 platelet substudy Journal of Thrombosis and Haemostasis: Jth 10(10): 2199-2202